- Home
- BNTX vs DTE Comparison
BNTX vs DTE Comparison
Compare BNTX & DTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- DTE
- Stock Information
- Founded
- BNTX 2008
- DTE 1903
- Country
- BNTX Germany
- DTE United States
- Employees
- BNTX N/A
- DTE N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- DTE Electric Utilities: Central
- Sector
- BNTX Health Care
- DTE Utilities
- Exchange
- BNTX Nasdaq
- DTE Nasdaq
- Market Cap
- BNTX 25.0B
- DTE 28.2B
- IPO Year
- BNTX 2019
- DTE N/A
- Fundamental
- Price
- BNTX $107.84
- DTE $132.41
- Analyst Decision
- BNTX Strong Buy
- DTE Buy
- Analyst Count
- BNTX 18
- DTE 14
- Target Price
- BNTX $141.55
- DTE $140.00
- AVG Volume (30 Days)
- BNTX 914.5K
- DTE 1.4M
- Earning Date
- BNTX 08-04-2025
- DTE 07-24-2025
- Dividend Yield
- BNTX N/A
- DTE 3.29%
- EPS Growth
- BNTX N/A
- DTE 20.97
- EPS
- BNTX N/A
- DTE 7.39
- Revenue
- BNTX $2,968,331,171.00
- DTE $13,657,000,000.00
- Revenue This Year
- BNTX N/A
- DTE $8.06
- Revenue Next Year
- BNTX $10.68
- DTE $2.97
- P/E Ratio
- BNTX N/A
- DTE $17.92
- Revenue Growth
- BNTX 0.61
- DTE 11.89
- 52 Week Low
- BNTX $76.53
- DTE $108.40
- 52 Week High
- BNTX $131.49
- DTE $140.39
- Technical
- Relative Strength Index (RSI)
- BNTX 53.44
- DTE 45.36
- Support Level
- BNTX $102.57
- DTE $130.94
- Resistance Level
- BNTX $108.39
- DTE $132.74
- Average True Range (ATR)
- BNTX 2.66
- DTE 1.64
- MACD
- BNTX -0.22
- DTE -0.10
- Stochastic Oscillator
- BNTX 66.59
- DTE 34.97
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About DTE DTE Energy Company
DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.